No Data
Wells Fargo Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating
Top Gap Ups and Downs on Monday: TSLA, NET, STLA and More
Morgan Stanley Bullish on Medtech in 2025, Upgrades 5 Stocks
Morgan Stanley Downgrades Bausch & Lomb to Equal-Weight, Announces $19 Price Target
Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue Eye Care Recycling Programs
Wells Fargo Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Maintains Target Price $26
Benjamin’s : New CEO